Search Results for: RedHill Biopharma Announces New US
Articles
June 6, 2018
RedHill Biopharma Announces New US Patent for its Experimental Ebola Therapy June 6, 2018
RedHill Biopharma Ltd. recently announced the United States Patent and Trademark Office (USPTO) has issued a patent covering RedHill’s proprietary experimental therapy for the treatment of Ebola virus disease. The patent is expected to be valid until 2035.
December 10, 2018
RedHill Biopharma Announces Positive Top-Line Results From Confirmatory Phase 3 Study December 10, 2018
RedHill Biopharma Ltd. recently announced positive top-line results from the ERADICATE Hp2 study, a two-arm, randomized, double-blind, active comparator-controlled, confirmatory...
